Selected Publications
- Gerner et al., Packed red blood cells inhibit T-cell activation via ROS-dependent signaling pathways. J Biol Chem. 2021 Jan-Jun;296:100487. doi: 10.1016/j.jbc.2021.100487.
- Ziegler et al., Attenuation of canonical NF-κB signaling maintains function and stability of human Treg. FEBS J. 2021 Jan;288(2):640-662. doi: 10.1111/febs.15361.
- Gerner et al., The TGF-b/SOX4 axis and ROS-driven autophagy co-mediate CD39 expression in regulatory T-cells; FASEB J. 2020 Jun;34(6):8367-8384. doi: 10.1096/fj.201902664.
- Gerner et al., Proteome Analysis Reveals Distinct Mitochondrial Functions Linked to Interferon Response Patterns in Activated CD4+ and CD8+ T Cells; Front Pharmacol. 2019 Jul 10;10:727. doi: 10.3389/fphar.2019.00727
- Schmetterer et al., Overexpression of PDE4A Acts as Checkpoint Inhibitor Against cAMP-Mediated Immunosuppression in vitro. Front Immunol. 2019 Jul 30;10:1790. doi: 10.3389/fimmu.2019.01790
- Schmidt et al., Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation. Sci Rep. 2017 Feb 7;7:42191. doi: 10.1038/srep42191
- Prodinger et al., The tryptophan metabolite picolinic acid suppresses proliferation and metabolic activity of CD4+ T cells and inhibits c-Myc activation. J Leukoc Biol. 2016 Apr;99(4):583-94. doi: 10.1189/jlb.3A0315-135R
- Ratzinger et al., Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity. Sci Rep. 2014 Dec 11;4:7438. doi: 10.1038/srep07438
- Schmetterer et al., STAT3 governs hyporesponsiveness and granzyme B-dependent suppressive capacity in human CD4+ T cells. FASEB J. 2015 Mar;29(3):759-71. doi: 10.1096/fj.14-257584